Amy Moore

Amy Moore has extensive experience in quality assurance and compliance within the pharmaceutical and healthcare industries. Amy currently works as an Associate Director of Research Quality Assurance at Sage Therapeutics, where they assess and mitigates compliance risks, develops quality metrics, and provides QA guidance for essential tremor program. Prior to this, they were a Senior Manager of Quality Oversight at ICON plc, where they led the implementation of client-specific quality oversight plans and provided expertise in global GCP regulations. Amy also worked as a Manager in Management Technology and Consulting at Mazars USA LLP, where they audited various service providers and collaborated on CAPAs. Additionally, Amy held positions such as a Clinical Quality Assurance Manager at Liquidia Technologies, a Compliance Audit and Risk Assurer at IBM Watson Health, a Senior Quality Assurance Specialist at RTI Health Solutions, and an Associate Director of Computer Systems Quality Assurance at INC Research. Amy began their career as a Senior Auditor at Quintiles, where they evaluated compliance policies and procedures and conducted quality assurance consultancy activities. Throughout their career, Amy demonstrated leadership skills, managed compliance issues, developed relationships with internal and external stakeholders, and contributed to efficient and compliant processes.

Amy Moore has a Bachelor's degree in Biology from Meredith College. Amy also has additional certifications, including the ISO 13485:2016 Lead Auditor (TPECS) from BSI, obtained in May 2017, and the IBM Volunteers Bronze Award from IBM. The specific details regarding their education history at North Carolina State University, such as the degree and field of study, are not provided.